P146: Melanoma organoids as platform for testing oncological therapies
FAU own research funding: EFI / IZKF / EAM ...
Start date : 01.07.2024
End date : 30.06.2025
Project details
Scientific Abstract
Despite good overall response rates, there are also high rates of resistance under immunotherapy and targeted therapy in the treatment of melanoma. Thus, new therapeutic options are needed and we need laboratory test systems to allow a prediction of treatment response by therapeutics. 3D organoids can be a promising tool in this regard. Therefore, in this project, melanoma-derived organoids are cultivated as a test platform to predict in vitro tumour therapy response in vivo.
Involved:
Contributing FAU Organisations:
Interdisziplinäres Zentrum für Klinische Forschung (IZKF)
Department of Dermatology
Medizinische Fakultät
